Related Experiment Video
Updated: Jun 27, 2026

Quantifying the Antifungal Activity of Peptides Against Candida albicans
Published on: January 13, 2023
Effects of hydrophobicity on the antifungal activity of alpha-helical antimicrobial peptides
Ziqing Jiang1, Bart Jan Kullberg, Hein van der Lee
1Department of Biochemistry & Molecular Genetics, School of Medicine, University of Colorado-Denver, Aurora, CO 80045, USA.
Abstract:
We utilized a series of analogs of D-V13K (a 26-residue amphipathic alpha-helical antimicrobial peptide, denoted D1) to compare and contrast the role of hydrophobicity on antifungal and antibacterial activity to the results obtained previously with Pseudomonas aeruginosa strains. Antifungal activity for zygomycota fungi decreased with increasing hydrophobicity (D-V13K/A12L/A20L/A23L, denoted D4, the most hydrophobic analog was sixfold less active than D1, the least hydrophobic analog). In contrast, antifungal activity for ascomycota fungi increased with increasing hydrophobicity (D4, the most hydrophobic analog was fivefold more active than D1). Hemolytic activity is dramatically affected by increasing hydrophobicity with peptide D4 being 286-fold more hemolytic than peptide D1. The therapeutic index for peptide D1 is 1569-fold and 62-fold better for zygomycota fungi and ascomycota fungi, respectively, compared with peptide D4. To reduce the hemolytic activity of peptide D4 and improve/maintain the antifungal activity of D4, we substituted another lysine residue in the center of the non-polar face (V16K) to generate D5 (D-V13K/V16K/A12L/A20L/A23L). This analog D5 decreased hemolytic activity by 13-fold, enhanced antifungal activity to zygomycota fungi by 16-fold and improved the therapeutic index by 201-fold compared with D4 and represents a unique approach to control specificity while maintaining high hydrophobicity in the two hydrophobic segments on the non-polar face of D5.
Insights
Hydrophobicity impacts antimicrobial peptide activity differently across fungal types. Increasing hydrophobicity boosts activity against ascomycota but reduces it against zygomycota, while also increasing hemolytic activity. A modified peptide, D5, balances these effects.
Area of Science:
- Biochemistry
- Microbiology
- Medicinal Chemistry
Background:
- Antimicrobial peptides (AMPs) are crucial in innate immunity.
- Hydrophobicity is a key factor influencing AMP activity and toxicity.
- Understanding structure-activity relationships is vital for developing effective antimicrobial agents.
Purpose of the Study:
- To investigate the role of hydrophobicity in the antifungal and antibacterial activity of D-V13K peptide analogs.
- To compare the effects of varying hydrophobicity on different fungal classes (Zygomycota and Ascomycota).
- To assess the impact of hydrophobicity on hemolytic activity and optimize peptide design for improved therapeutic index.
Main Methods:
- Synthesis and characterization of D-V13K peptide analogs with varying hydrophobicity.
- Antifungal susceptibility testing against Zygomycota and Ascomycota fungi.
- Antibacterial activity assessment against Pseudomonas aeruginosa.
- Hemolytic activity assays.
- Therapeutic index calculation.
Main Results:
- Antifungal activity against Zygomycota decreased with increasing hydrophobicity, while activity against Ascomycota increased.
- Hemolytic activity significantly increased with higher hydrophobicity, with analog D4 being 286-fold more hemolytic than D1.
- The therapeutic index was substantially better for the less hydrophobic D1 compared to D4.
- Modified analog D5 demonstrated reduced hemolytic activity, enhanced antifungal activity against Zygomycota, and a 201-fold improved therapeutic index over D4.
Conclusions:
- Hydrophobicity plays a dual role in the antifungal activity of D-V13K analogs, depending on the fungal class.
- High hydrophobicity leads to increased toxicity (hemolysis), necessitating careful optimization.
- Peptide analog D5 represents a successful strategy for balancing antifungal efficacy and reducing hemolytic activity, offering a promising therapeutic approach.
More Related Videos
10:13Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
Published on: August 11, 2018
05:08Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
Published on: September 20, 2017
Related Concept Videos
Antifungal Agents
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Amino acids
Antimicrobial Effectiveness